The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters
Open accessAbstract
The pathogenesis of multiple sclerosis (MS), an autoimmune disease affecting the brain and spinal cord, remains poorly understood. Patients with MS typically present with recurrent episodes of neurological dysfunctions such as blindness, paresis, and sensory disturbances. Studies on experimental autoimmune encephalomyelitis (EAE) animal models have led to a number of testable hypotheses including a hypothetical role of altered gut microbiota in the development of MS. To investigate whether gut microbiota in patients with MS is altered, we compared the gut microbiota of 20 Japanese patients with relapsing-remitting (RR) MS (MS20) with that of 40 healthy Japanese subjects (HC40) and an additional 18 healthy subjects (HC18). All the HC18 subjects repeatedly provided fecal samples over the course of months (158 samples in total). Analysis of the bacterial 16S ribosomal RNA (rRNA) gene by using a high-throughput culture-independent pyrosequencing method provided evidence of a moderate dysbiosis in the structure of gut microbiota in patients with MS. Furthermore, we found 21 species that showed significant differences in relative abundance between the MS20 and HC40 samples. On comparing MS samples to the 158 longitudinal HC18 samples, the differences were found to be reproducibly significant for most of the species. These taxa comprised primarily of clostridial species belonging to Clostridia clusters XIVa and IV and Bacteroidetes. The phylogenetic tree analysis revealed that none of the clostridial species that were significantly reduced in the gut microbiota of patients with MS overlapped with other spore-forming clostridial species capable of inducing colonic regulatory T cells (Treg), which prevent autoimmunity and allergies; this suggests that many of the clostridial species associated with MS might be distinct from those broadly associated with autoimmune conditions. Correcting the dysbiosis and altered gut microbiota might deserve consideration as a potential strategy for the prevention and treatment of MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bacteria belonging to the Clostridia family contribute to the suppression of pathological autoimmunity (134, 139–143).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [134]
In the citing paper
“Interestingly, even MS patients with active disease have an altered microbiota compared to patients in the remission phase, which in turn have a microbiota more similar to healthy controls (25, 134–138).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 810
Kumar, N., Sahoo, N. K., Mehan, S., & verma, B. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104547 · Cited by 41
Guan, Y., Tang, G., Li, L., Shu, J., Zhao, Y., Huang, L., & Tang, J. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01484-9 · Cited by 41
The chicken or the egg dilemma: intestinal dysbiosis in multiple sclerosis
Ochoa‐Repáraz, J., Mágori, K., & Kasper, L. H. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.01.18 · Cited by 40
Emerging Role of Diet and Microbiota Interactions in Neuroinflammation
Janakiraman, M., & Krishnamoorthy, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02067 · Cited by 39
Bragg, M., Freeman, E. W., Lim, H. C., Songsasen, N., & Muletz‐Wolz, C. R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.590212 · Cited by 40
Hosseini, S. A., Nematollahi, S., Husain, D., Banaei-Jahromi, N., Majdinasab, N., & Hosseini, S. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.901846 · Cited by 40
Wu, J., Zou, J., Hu, E.-D., Chen, D., Chen, L., Lu, F., Xu, L., Zheng, M., Li, H., Huang, Y., et al. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.08.005 · Cited by 38
Gut microbiota and metabolites are linked to disease progression in multiple sclerosis
Schwerdtfeger, L., Montini, F., Lanser, T. B., Ekwudo, M. N., Zurawski, J. D., Tauhid, S., Glanz, B. I., Chu, R., Bakshi, R., Chitnis, T., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102055 · Cited by 45
Dietary fatty acids and susceptibility to multiple sclerosis
Haase, S., Haghikia, A., Gold, R., & Linker, R. A. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458517737372 · Cited by 36
Kap, Y. S., Bus‐Spoor, C., van Driel, N., Dubbelaar, M. L., Grit, C., Kooistra, S. M., Fagrouch, Z. C., Verschoor, E. J., Bauer, J., Eggen, B. J. L., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800822 · Cited by 36
Papel de la microbiota intestinal en el desarrollo de diferentes enfermedades neurológicas
Castillo-Álvarez, F., & Marzo-Sola, M. E. (2019) · Neurología · doi:10.1016/j.nrl.2019.03.017 · Cited by 40
Wang, S., Chen, H., Wen, X., Mu, J., Sun, M., Song, X., Liu, B., Chen, J., & Fan, X. (2021) · Journal of Immunology Research · doi:10.1155/2021/4400428 · Cited by 37
Role of the gut microbiota in the development of various neurological diseases
Castillo-Álvarez, F., & Marzo-Sola, M. E. (2021) · Neurología (English Edition) · doi:10.1016/j.nrleng.2019.03.026 · Cited by 40
Caligiore, D., Giocondo, F., & Silvetti, M. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.09.007 · Cited by 40
Czaja, A. J. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i45.6579 · Cited by 35
Yacoub, R., Jacob, A., Wlaschin, J. J., McGregor, M. M., Quigg, R. J., & Alexander, J. J. (2017) · Immunobiology · doi:10.1016/j.imbio.2017.11.004 · Cited by 37
Gut environmental factors and multiple sclerosis
Miyake, S., & Yamamura, T. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.07.015 · Cited by 36
Nutritional Intervention as an Essential Part of Multiple Sclerosis Treatment?
Penesová, A., Dean, Z., Kollár, B., Havranová, A., Imrich, R., Vlček, M., & Rádiková, Ž. (2018) · Physiological Research · doi:10.33549/physiolres.933694 · Cited by 35
Regulatory T cells in multiple sclerosis
Kimura, K. (2020) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12591 · Cited by 37
Kohl, H. M., Castillo, A., & Ochoa‐Repáraz, J. (2020) · Diseases · doi:10.3390/diseases8030033 · Cited by 36
Metagenomic Analysis of Cerebrospinal Fluid from Patients with Multiple Sclerosis
Perlejewski, K., Bukowska‐Ośko, I., Nakamura, S., Motooka, D., Stokowy, T., Płoski, R., Rydzanicz, M., Zakrzewska‐Pniewska, B., Podlecka‐Piętowska, A., Nojszewska, M., et al. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_25 · Cited by 35
How does Quorum Sensing of Intestinal Bacteria Affect Our Health and Mental Status?
Dicks, L. M. T. (2022) · Microorganisms · doi:10.3390/microorganisms10101969 · Cited by 39
Montgomery, T. L., Peipert, D., & Krementsov, D. N. (2024) · Immunological Reviews · doi:10.1111/imr.13343 · Cited by 38
Toribio-Mateas, M. A. (2018) · Microorganisms · doi:10.3390/microorganisms6020035 · Cited by 37
Microbial monotherapy with Prevotella histicola for patients with multiple sclerosis
Mangalam, A. K., & Murray, J. A. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1555473 · Cited by 34
Oligosaccharides Modulate Rotavirus-Associated Dysbiosis and TLR Gene Expression in Neonatal Rats
Azagra-Boronat, I., Massot‐Cladera, M., Knipping, K., Land, B. V., Tims, S., Stahl, B., Knol, J., Garssen, J., Franch, À., Castell, M., et al. (2019) · Cells · doi:10.3390/cells8080876 · Cited by 35
Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis
Maglione, A., Zuccalà, M., Tosi, M., Clerico, M., & Rolla, S. (2021) · Genes · doi:10.3390/genes12081181 · Cited by 34
Meta-analysis identifies common gut microbiota associated with multiple sclerosis
Lin, Q., Dorsett, Y., Mirza, A., Tremlett, H. L., Piccio, L. M., Longbrake, E. E., Choileáin, S. N., Hafler, D. A., Cox, L. M., Weiner, H. L., et al. (2024) · Genome Medicine · doi:10.1186/s13073-024-01364-x · Cited by 41
The gut-brain axis and beyond: Microbiome control of spinal cord injury pain in humans and rodents
Bannerman, C. A., Douchant, K., Sheth, P. M., & Ghasemlou, N. (2020) · Neurobiology of Pain · doi:10.1016/j.ynpai.2020.100059 · Cited by 34
A potential impact of Helicobacter pylori -related galectin-3 in neurodegeneration
Boziki, M. K., Pοlyzos, S. A., Deretzi, G., Kazakos, E. I., Katsinelos, P., Doulberis, M., Kotronis, G., Giartza‐Taxidou, E., Laskaridis, L., Tzivras, D., et al. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.12.003 · Cited by 32
Stanisavljević, S., Dinić, M., Jevtić, B., Nikolovski, N., Momčilović, M. B., Đokić, J., Golić, N., Stojković, M. M., & Miljković, D. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00942 · Cited by 30
Gut Microbiota and Disorders of the Central Nervous System
Vuotto, C., Battistini, L., Caltagirone, C., & Borsellino, G. (2020) · The Neuroscientist · doi:10.1177/1073858420918826 · Cited by 37
Gut commensals, dysbiosis, and immune response imbalance in the pathogenesis of multiple sclerosis
Brown, J. S., Quattrochi, B., Everett, C., Hong, B., & Cervantes, J. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520928301 · Cited by 33
Gargano, F., Guerrera, G., Piras, E., Serafini, B., Paola, M. D., Rizzetto, L., Buscarinu, M. C., Annibali, V., Vuotto, C., Bardi, M. D., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.890298 · Cited by 32
Marć, M. A., Jastrząb, R., & Mytych, J. (2022) · Nutrients · doi:10.3390/nu14193967 · Cited by 33
Rodriguez, M., Wootla, B., & Anderson, G. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160915160520 · Cited by 32
Williams, L. M., & Cao, S. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108605 · Cited by 33
Ferreira, T. B., Hygino, J., Wing, A. C., Kasahara, T. M., Sacramento, P. M., Camargo, S. M. D. G. G., Rueda, F., Alves‐Leon, S. V., Alvarenga, R. M. P., Vasconcelos, C. C. F., et al. (2017) · Immunology · doi:10.1111/imm.12872 · Cited by 32
Andersen-Ranberg, E., Berendt, M., & Gredal, H. (2021) · The Veterinary Journal · doi:10.1016/j.tvjl.2021.105678 · Cited by 31
Barone, M., Mendozzi, L., D’Amico, F., Saresella, M., Rampelli, S., Piancone, F., Rosa, F. L., Marventano, I., Clerici, M., d’Arma, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137173 · Cited by 32
The second brain: The connection between gut microbiota composition and multiple sclerosis
Farshbafnadi, M., Agah, E., & Rezaei, N. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577700 · Cited by 31
Gut inflammation in CVID: causes and consequences
Andersen, I., & Jørgensen, S. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.2008241 · Cited by 31
Mucosal Immunity and the Gut-Microbiota-Brain-Axis in Neuroimmune Disease
Sterling, K. G., Dodd, G. K., Alhamdi, S., Asimenios, P. G., Dagda, R. K., Meirleir, K. L. D., Hudig, D., & Lombardi, V. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113328 · Cited by 34
Vakili, K. G., Fathi, M., Yaghoobpoor, S., Sayehmiri, F., Nazerian, Y., Nazerian, A., Mohamadkhani, A., Khodabakhsh, P., Réus, G. Z., Hajibeygi, R., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.983089 · Cited by 32
Gut dysbiosis in autoimmune diseases: Association with mortality
Chang, S.-H., & Choi, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1157918 · Cited by 36
Gut microbiome and pediatric multiple sclerosis
Tremlett, H. L., & Waubant, E. L. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458517737369 · Cited by 31
Specific microbial ratio in the gut microbiome is associated with multiple sclerosis
Ghimire, S., Lehman, P., Meza, L. S. A., Shahi, S. K., Hoang, J., Olalde, H. M., Paullus, M., Cherwin, C. H., Wang, K., Gill, C. M., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2413953122 · Cited by 32
Can Microbiota Research Change Our Understanding of Neurodegenerative diseases?
Scheperjans, F. (2016) · Neurodegenerative Disease Management · doi:10.2217/nmt-2015-0012 · Cited by 31
Emerging Concepts on the Gut Microbiome and Multiple Sclerosis
Glenn, J. D., & Mowry, E. M. (2016) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2015.0177 · Cited by 30
Castillo-Álvarez, F., Pérez‐Matute, P., Oteo, J. A., & Marzo-Sola, M. E. (2018) · Neurología · doi:10.1016/j.nrl.2018.04.006 · Cited by 30
Gut and oral microbiota in autoimmune liver disease
Abe, K., Fujita, M., Hayashi, M., Okai, K., Takahashi, A., & Ohira, H. (2019) · FUKUSHIMA JOURNAL OF MEDICAL SCIENCE · doi:10.5387/fms.2019-21 · Cited by 30
One, No One, and One Hundred Thousand: T Regulatory Cells' Multiple Identities in Neuroimmunity
Sambucci, M., Gargano, F., Guerrera, G., Battistini, L., & Borsellino, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02947 · Cited by 31
Gut microbiome-modulated dietary strategies in EAE and multiple sclerosis
Hoffman, K. R., Doyle, W. J., Schumacher, S. M., & Ochoa‐Repáraz, J. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1146748 · Cited by 32
Game of microbes: the battle within – gut microbiota and multiple sclerosis
Turner, T.-A. J., Lehman, P., Ghimire, S., Shahi, S. K., & Mangalam, A. K. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2387794 · Cited by 33
Ladakis, D. C., Harrison, K. L., Smith, M. D., Solem, K., Gadani, S. P., Jank, L., Hwang, S. A., Farhadi, F., Dewey, B. E., Fitzgerald, K. C., et al. (2024) · Med · doi:10.1016/j.medj.2024.09.011 · Cited by 30
Insights into the Mechanisms That May Clarify Obesity as a Risk Factor for Multiple Sclerosis
Huitema, M. J. D., & Schenk, G. J. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0827-5 · Cited by 29
Chen, Z., Maqbool, J., Sajid, F., Hussain, G., & Sun, T. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104675 · Cited by 28
The Emerging World of Microbiome in Autoimmune Disorders: Opportunities and Challenges
Mangalam, A. K., Yadav, M., & Yadav, R. (2021) · Indian Journal of Rheumatology · doi:10.4103/injr.injr_210_20 · Cited by 29
Microglial cells: Sensors for neuronal activity and microbiota-derived molecules
D’Alessandro, G., Marrocco, F., & Limatola, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1011129 · Cited by 31
Gut Microbiota Changes during Dimethyl Fumarate Treatment in Patients with Multiple Sclerosis
Ferri, C., Castellazzi, M., Merli, N., Laudisi, M., Baldin, E., Baldi, E., Mancabelli, L., Ventura, M., & Pugliatti, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032720 · Cited by 32
Review: The Nutritional Management of Multiple Sclerosis With Propionate
Tobin, D. P., Vige, R., & Calder, P. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.676016 · Cited by 28
Melamed, E., Palmer, J. L., & Fonken, C. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1019877 · Cited by 26
Prado, C. E., Espinoza, A., Martínez, E., Petrosino, J. F., Riquelme, E. M., Martín, A. J. M., & Pacheco, R. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02815-9 · Cited by 32
Khadka, S., Omura, S., Sato, F., Nishio, K., Kakeya, H., & Tsunoda, I. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.772962 · Cited by 28
How Microbiota-Derived Metabolites Link the Gut to the Brain during Neuroinflammation
Rebeaud, J., Peter, B., & Pot, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710128 · Cited by 28
Carotenoids and Their Interaction with the Immune System
Medina-García, M., Baeza-Morales, A., Martínez-Peinado, P., Pascual-García, S., Pujalte-Satorre, C., Martínez‐Espinosa, R. M., & Sempere-Ortells, J. M. (2025) · Antioxidants · doi:10.3390/antiox14091111 · Cited by 32
Dziedzic, A., & Saluk, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214478 · Cited by 31
Yousefi, B., Babaeizad, A., Banihashemian, S. Z., Feyzabadi, Z. K., Dadashpour, M., Pahlevan, D., Ghaffari, H., & Eslami, M. (2022) · Current Microbiology · doi:10.1007/s00284-022-03150-7 · Cited by 29
The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease
Ochoa‐Repáraz, J., & Kasper, L. H. (2016) · Translational research · doi:10.1016/j.trsl.2016.07.016 · Cited by 28
Perturbed Microbiota/Immune Homeostasis in Multiple Sclerosis
Sterlin, D., Larsen, M., Fadlallah, J., Parizot, C., Vignes, M., Autaa, G., Dorgham, K., Juste, C., Lepage, P., Aboab, J., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000997 · Cited by 30
How the gut microbiota impacts neurodegenerative diseases by modulating CNS immune cells
Schaible, P., Henschel, J., & Erny, D. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03371-0 · Cited by 32
Fettig, N. M., & Osborne, L. C. (2021) · Microbes and Infection · doi:10.1016/j.micinf.2021.104814 · Cited by 26
Diebold, M., Meola, M., Purushothaman, S., Siewert, L. K., Pössnecker, E., Roloff, T. C., Lindberg, R. L. P., Kühle, J., Kappos, L., Derfuss, T., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2147055 · Cited by 27
Berre, L. L., Rousse, J., Gourraud, P., Imbert‐Marcille, B., Salama, A., Evanno, G., Sémana, G., Nicot, A. B., Dugast, E., Guérif, P., et al. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.05.006 · Cited by 26
Gut Microbiota Changes in Experimental Autoimmune Encephalomyelitis and Cuprizone Mice Models
Moles, L., Egimendia, A., Osorio-Querejeta, I., Iparraguirre, L., Alberro, A., Suárez, J. A., Sepúlveda, L., Castillo‐Triviño, T., Muñoz‐Culla, M., Ramos‐Cabrer, P., et al. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00695 · Cited by 28
Merchak, A. R., Cahill, H. J., Brown, L. C., Brown, R. M., Rivet-Noor, C. R., Beiter, R. M., Slogar, E. R., Olgun, D. G., & Gaultier, A. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002000 · Cited by 25
The role of multiple sclerosis therapies on the dynamic of human gut microbiota
Văcăraș, V., Muresanu, D. F., Buzoianu, A. D., Nistor, C., Vesa, Ș. C., Paraschiv, A.-C., Botos-Vacaras, D., Văcăraș, C., & Vithoulkas, G. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578087 · Cited by 28
Environmental risk factors for multiple sclerosis in Japanese people
Sakoda, A., Matsushita, T., Nakamura, Y., Watanabe, M., Shinoda, K., Masaki, K., Isobe, N., Yamasaki, R., & Kira, J. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101872 · Cited by 25
Gut microbiota in Immunoglobulin A Nephropathy: a Malaysian Perspective
Sugurmar, A. N. K., Mohd, R., Shah, S. A., Neoh, H., & Cader, R. A. (2021) · BMC Nephrology · doi:10.1186/s12882-021-02315-z · Cited by 25
Pelvic Floor Dysfunctions and Their Rehabilitation in Multiple Sclerosis
Sparaco, M., & Bonavita, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11071941 · Cited by 24
D’Anca, M., Buccellato, F. R., Tartaglia, G. M., FABBRO, M. D., Muti, P. C., Scarpini, E. A., Galimberti, D., & Ghezzi, L. (2023) · Applied Sciences · doi:10.3390/app13105881 · Cited by 26
Digehsara, S. G., Name, N., Esfandiari, B., Karim, E., Taheri, S., Ebrahimi, M. T., & Arasteh, J. (2020) · Inflammation · doi:10.1007/s10753-020-01339-1 · Cited by 24
Ullah, H., Товчига, О. В., Daglia, M., & Khan, H. Z. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210217084827 · Cited by 25
Gut microbiome research in multiple sclerosis
Takewaki, D., & Yamamura, T. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.05.001 · Cited by 22
Gut flora in multiple sclerosis: implications for pathogenesis and treatment
Zhang, W., Wang, Y., Zhu, M., Liu, K., & Zhang, H. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.387974 · Cited by 24
Farowski, F., Els, G., Tsakmaklis, A., Higgins, P. G., Kahlert, C. R., Stein‐Thoeringer, C. K., Bobardt, J. S., Dettmer‐Wilde, K., Oefner, P. J., Vehreschild, J. J., et al. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1502536 · Cited by 27
Bottoms up: the role of gut microbiota in brain health
Radisavljevic, N., Cirstea, M. S., & Finlay, B. B. (2018) · Environmental Microbiology · doi:10.1111/1462-2920.14506 · Cited by 24
Aghamohammadi, D., Ayromlou, H., Dolatkhah, N., Jahanjoo, F., & Shakouri, S. K. (2019) · Trials · doi:10.1186/s13063-019-3454-9 · Cited by 22
Choi, J. G., Huh, E., Kim, N., Kim, D., & Oh, M. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217194 · Cited by 22
Tong, J., Satyanarayanan, S. K., & Su, H. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.08.027 · Cited by 24
The multiple sclerosis microbiome?
Tremlett, H. L., & Waubant, E. L. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.01.63 · Cited by 21
The Role for Exosomal microRNAs in Disruption of Regulatory T Cell Homeostasis in Multiple Sclerosis
Kimura, K., Hohjoh, H., & Yamamura, T. (2018) · Journal of Experimental Neuroscience · doi:10.1177/1179069518764892 · Cited by 23
Gut microbiota in multiple sclerosis and animal models
Schumacher, S. M., Doyle, W. J., Hill, K., & Ochoa‐Repáraz, J. (2025) · The FEBS Journal · doi:10.1111/febs.17161 · Cited by 21
Hu, M., Du, Y., Li, W., Zong, X., Du, W., Sun, H., Liu, H., Zhao, K., Li, J., Farooq, M. Z., et al. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400251 · Cited by 25
Träger, C., Kaiser, M., Freudenstein, D., Heckscher, S., Dettmer, K., Oefner, P. J., Liebisch, G., Hiergeist, A., Gessner, A., Lee, D.-H., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105743 · Cited by 21
Omura, S., Sato, F., Park, A.-M., Fujita, M., Khadka, S., Nakamura, Y., Katsuki, A., Nishio, K., Gavins, F. N. E., & Tsunoda, I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01138 · Cited by 23
Becker, A., Abuazab, M., Schwiertz, A., Walter, S., Fassbender, K. C., Fousse, M., & Unger, M. M. (2021) · Autoimmunity Highlights · doi:10.1186/s13317-021-00149-1 · Cited by 23
Shahi, S. K., Ali, S., Jaime, C. M., Guseva, N. V., & Mangalam, A. K. (2021) · ImmunoHorizons · doi:10.4049/immunohorizons.2100024 · Cited by 20
The gut microbiome molecular mimicry piece in the multiple sclerosis puzzle
Elsayed, N. S., Aston, P., Bayanagari, V. R., & Shukla, S. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.972160 · Cited by 22
Zhang, M., Tang, H., Chen, Y., Chen, Z., Xu, Y., Fu, X., Sun, Y., & Zhao, Z. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116114 · Cited by 24
Metadata
- Authors
- Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., Chihara, N., Tomita, A., Sato, W., Kim, S.-W., Morita, H., Hattori, M., & Yamamura, T.
- Affiliations
- Juntendo University (JP)
- RIKEN Center for Integrative Medical Sciences (JP)
- The University of Tokyo (JP)
- National Institute of Neuroscience (JP)
- Azabu University (JP)
- Corresponding author
- Hattori, Masahira
- Yamamura, Takashi
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-09-14
- Volume
- 10
- Issue
- 9
- Pages
- e0137429
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4569432
- OpenAlex
- W2200372542
- Cited by
- 809
- References
- 41
- Citations by year
- 2026: 49 · 2025: 61 · 2024: 83 · 2023: 68 · 2022: 91 · 2021: 89 · 2020: 89 · 2019: 76 · 2018: 85 · 2017: 76 · 2016: 38 · 2015: 2
- FWCI
- 29.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministry of Health, Labour and Welfare
- University of Tokyo
- Japan Society for the Promotion of Science (24229006, 26293234)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- multiple sclerosis, gut microbiota, dysbiosis, Clostridium XIVa, Bacteroidetes, relapsing-remitting multiple sclerosis, experimental autoimmune encephalomyelitis, regulatory T cells, autoimmunity, 16S rRNA gene sequencing, fecal microbiota
- MeSH terms
- Gastrointestinal Microbiome, Adult, Clostridium, Female, Humans, Japan, Male, Multiple Sclerosis, RNA, Bacterial, RNA, Ribosomal, 16S, Sequence Analysis, RNA, Bacteroidetes, High-Throughput Nucleotide Sequencing, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
